Maine § 22 §1711-E Confidentiality of prescription drug information

Maine Statutes

§ 22 §1711-E — Confidentiality of prescription drug information

Maine § 22 §1711-E

Title 22HEALTH AND WELFARE

Part 4HOSPITALS AND MEDICAL CARE

Ch. 401GENERAL PROVISIONS

This text of Maine § 22 §1711-E (Confidentiality of prescription drug information) is published on Counsel Stack Legal Research, covering Maine primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Me. Rev. Stat. tit. 22, § 22 §1711-E (2026).

Text

1.Definitions. As used in this section, unless the context otherwise indicates, the following terms have the following meanings. 1-A. Findings. 1-B. Purposes.

2.Confidentiality of prescription drug information that identifies the individual. A carrier or prescription drug information intermediary may not license, use, sell, transfer or exchange for value, for any marketing purpose, prescription drug information that identifies directly or indirectly the individual who is prescribed the prescription drug. 2-A. Confidentiality of prescription drug information that identifies the prescriber.

3.Enforcement. A violation of subsection 2 is a violation of the Maine Unfair Trade Practices Act.

4.Confidentiality protection procedures.

5.Rules. The department shall adopt rules to implement this

Free access — add to your briefcase to read the full text and ask questions with AI

1.
Definitions.
As used in this section, unless the context otherwise indicates, the following terms have the following meanings.
1-A.
Findings.
1-B.
Purposes.
2.
Confidentiality of prescription drug information that identifies the individual.
A carrier or prescription drug information intermediary may not license, use, sell, transfer or exchange for value, for any marketing purpose, prescription drug information that identifies directly or indirectly the individual who is prescribed the prescription drug.
2-A.
Confidentiality of prescription drug information that identifies the prescriber.
3.
Enforcement.
A violation of subsection 2 is a violation of the Maine Unfair Trade Practices Act.
4.
Confidentiality protection procedures.
5.
Rules.
The department shall adopt rules to implement this section. Rules adopted pursuant to this subsection are routine technical rules as defined by Title 5, chapter 375, subchapter 2‑A.

Legislative History

PL 2005, c. 589, §1 (NEW). PL 2007, c. 460, §1 (AMD). PL 2007, c. 695, Pt. C, §§6, 7 (AMD). PL 2011, c. 90, Pt. J, §10 (AMD). PL 2011, c. 443, §1 (AMD). PL 2011, c. 461, §1 (AMD). PL 2011, c. 494, §§1-6 (AMD). PL 2019, c. 469, §1 (AMD). PL 2019, c. 469, §9 (AFF).